US Broker Ratings

Quest Diagnostics (DGX) Stock Analysis: Navigating a 6.46% Potential Upside

Quest Diagnostics Incorporated (NYSE: DGX), a leading player in the healthcare sector, particularly within the diagnostics and research industry, presents an intriguing prospect for individual investors. As a company with..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring Potential Upside of Over 100% in the Biotech Arena

Summit Therapeutics Inc. (NASDAQ: SMMT) presents an intriguing opportunity for investors within the biotechnology sector, boasting a significant potential upside that could reach over 100%. This Miami-based biopharmaceutical company is..

Boston Scientific Corporation (BSX) Stock Analysis: A Potential 69.57% Upside with Strong Buy Ratings

Boston Scientific Corporation (NYSE: BSX) stands out in the healthcare sector as a formidable player in the medical devices industry. With a market capitalization of over $65.74 billion, it is..

UnitedHealth Group (UNH) Stock Analysis: Navigating a Robust Healthcare Behemoth with Strategic Insights

UnitedHealth Group Incorporated (NYSE: UNH) stands tall in the healthcare sector, renowned for its comprehensive services that span across healthcare plans and pharmacy care services. With a staggering market capitalization..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 21.25% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC), a key player in the healthcare sector, is drawing attention from investors with its strong market positioning and a promising potential upside of 21.25%...

Solventum Corporation (SOLV): Investor Outlook with a 3.30% Potential Upside in the Healthcare Sector

Solventum Corporation (NASDAQ: SOLV), a notable player in the healthcare sector, has garnered substantial attention from investors due to its diverse portfolio and strategic positioning within the medical instruments and..

Johnson & Johnson (JNJ) Stock Analysis: Robust Revenue Growth with Limited Upside Potential

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to command significant attention from investors. With a market capitalization of $613.02 billion, this American behemoth operates at..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Strong Buy Ratings Signal Potential 23% Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a formidable player in the healthcare sector specializing in both specialty and generic drug manufacturing, presents a compelling opportunity for investors seeking a robust pharmaceutical..

Gilead Sciences, Inc. (GILD) Stock Analysis: Strong Buy Ratings and a 23.22% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a leading biopharmaceutical company based in Foster City, California, is a compelling investment opportunity, particularly in the ever-evolving healthcare sector. With a market capitalization of..

BioNTech SE (BNTX) Investor Outlook: Potential Upside of 33.49% Amidst Revenue Challenges

BioNTech SE (BNTX), headquartered in Mainz, Germany, has become a prominent name in the biotechnology sector, particularly known for its groundbreaking work in immunotherapies and mRNA vaccine development. While its..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a Potential 42.74% Upside in the Healthcare Sector

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based software solutions for the life sciences industry, is catching the attention of investors with a potential upside of 42.74%, as indicated..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Unpacking its 6.02% Upside Potential

Investors seeking opportunities in the healthcare sector might find Zimmer Biomet Holdings, Inc. (NYSE: ZBH) an intriguing option. With a market capitalization of $18.01 billion, this U.S.-based medical device company..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Healthcare Giant with 39.78% Upside Potential

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leading player in the healthcare sector specializing in medical instruments and supplies, presents a compelling case for investors looking to capitalize on the growing..

Alcon Inc. (ALC) Stock Analysis: A Healthcare Giant with a 29.68% Upside Potential

For investors with an eye on the healthcare sector, Alcon Inc. (ALC) presents a compelling opportunity. Headquartered in Geneva, Switzerland, Alcon is a leader in the medical instruments and supplies..

Amgen Inc. (AMGN)

⚠️ No article content returned.

..

The Cigna Group (CI) Stock Analysis: Exploring a 20% Potential Upside for Investors

The Cigna Group (NYSE: CI), a prominent player in the healthcare sector, stands as a compelling choice for investors seeking both stability and growth potential in their portfolios. As of..

argenx SE (ARGX) Stock Analysis: An Upside of 17.57% Awaits Investors in Biotech Powerhouse

argenx SE (NASDAQ: ARGX), a leading player in the biotechnology sector, has garnered significant attention from investors thanks to its robust growth metrics and promising product pipeline. Headquartered in Amsterdam,..

Merck & Company, Inc. (MRK) Stock Analysis: Evaluating Growth Prospects Amid a 1.35% Potential Upside

Merck & Company, Inc. (NYSE: MRK) stands as a formidable player in the healthcare sector, with a market capitalization of $317.77 billion. Based in the United States, Merck operates globally,..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with 11.67% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) continues to capture the attention of investors in the biotechnology sector. With a current market cap of $124.7 billion, Vertex stands as a significant player..

Agilent Technologies, Inc. (A) Stock Analysis: Unpacking a 17.88% Potential Upside for Investors

Agilent Technologies, Inc. (NYSE: A), a pivotal player in the Healthcare sector, stands out in the Diagnostics & Research industry with a commendable market capitalization of $38.41 billion. As the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds